학술논문
Phase 1 multicenter, open-label study to establish the maximum tolerated dose (MTD) of two administration schedules of E7389 (eribulin) liposomal formulation in patients (pts) with solid tumors.
Document Type
Journal
Author
Zubairi, Ishtiaq Husain; Dean, Emma Jane; Molife, L. Rhoda; Lopez, Juanita Suzanne; Ranson, Malcolm; EI-Khouly, Fatima; Savulsky, Claudio Isaac; Reyderman, Larisa; Jia, Yan; Hutton, Emily; Morrison, Rosemary; Sweeting, Lorna; Greystoke, Alastair; Barriuso, Jorge; Kristeleit, Rebecca Sophie; Evans, T. R. Jeffry
Source
Subject
Language
English
ISSN
15277755